Close

OPKO Health (OPK) Reports In-Line Q4 EPS

Go back to OPKO Health (OPK) Reports In-Line Q4 EPS

Opko Health (OPK) PT Lowered to $8 at Jefferies Following 4Q Miss

March 2, 2017 7:38 AM EST

Jefferies lowered its price target on Opko Health (NASDAQ: OPK) to $8.00 (from $10.00) while maintaining a Hold rating. 4Q revenues of $275M came in well below consensus estimates, mainly on weaker BRLI trends.

Analyst Brandon Couillard commented, "4Q16 revenues came in well below... More